INSIGHTS
-
Biosimilars, Generics, and the New Cost-Control Countertrend in Pharmaceuticals
Prescription drug prices have long been a primary concern for patients, payers, and policymakers worldwide. In recent years, the surge of biosimilars and generics has emerged as a leading force in reshaping the economics of the pharmaceutical industry, promising not only reduced costs but also greater competition and accessibility. As of 2025, this movement —
-
Rising Cases of Enterovirus D68 in the United States
EV‑D68 is back on people’s radar. It’s a respiratory virus that most often looks like a regular cold, but it can sometimes cause worse breathing problems in children and, rarely, a serious neurological condition called acute flaccid myelitis (AFM). Over the last couple of years, multiple kinds of surveillance — clinical testing, pediatric hospital networks,
-
Are Seasonal Immunizations for RSV, COVID-19, and Influenza Safe?
A Comprehensive, Science-Based Guide for 2025–2026 As respiratory virus season returns in 2025–2026, many individuals and families are concerned about the safety of immunizations for respiratory syncytial virus (RSV), COVID-19, and influenza. With millions of people at risk each year, vaccines are vital public health tools, but questions about their safety, potential side effects, and
-
The ANDA Prioritization Pilot Is a Smart, Strategic Move to Rebuild U.S. Generic Drug Manufacturing Capacity
The Food and Drug Administration’s new ANDA Prioritization Pilot realigns regulatory incentives to reward onshore bioequivalence testing and U.S. manufacturing of finished dosage forms and active pharmaceutical ingredients (API), and it will strengthen supply‑chain resilience, lower inspection costs, and speed patient access to affordable generics. The policy leverages FDA review speed as a targeted market
-
Breast Cancer Awareness Month 2025 Why Early Detection, Education, and Advocacy Matter More Than Ever
October is Breast Cancer Awareness Month, a global campaign dedicated to raising awareness, promoting early detection, supporting patients, and funding research. Each year, millions of people worldwide unite under the pink ribbon symbol to honor survivors, remember those lost, and push forward in the fight against breast cancer. For us at GetASecondOpinion.ai, this month carries
-
ADRIANA Pain Medication – A Promising Future Alternative to Opioids
The opioid crisis has devastated communities worldwide, particularly in the United States, where opioid overdoses claimed more than 80,000 lives in 2023 alone.¹ While opioids like morphine and oxycodone remain powerful tools for managing severe pain, their risks —including addiction, overdose, and long-term dependence — have created an urgent need for safer alternatives. Enter ADRIANA
-
Fact-Checking Trump’s Autism Drug: Is Leucovorin a Breakthrough or Hype?
Leucovorin for Autism: Clinical Efficacy and Biochemical Mechanisms Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition, affecting communication, social interaction, and behavior, with rising global prevalence and substantial lifelong impact on families and public health systems.1 2 Despite decades of research, interventions addressing the core symptoms-language deficits, social challenges, and repetitive behaviors-remain limited. Leucovorin,
-
Why Unfilled Prescriptions Are a Silent Crisis in Healthcare
The Hidden Barrier to Better Health Every day, millions of prescriptions are written with the intent to improve patient outcomes, manage chronic conditions, or treat acute illnesses. Yet, a startling number of these prescriptions never make it to the pharmacy counter. This phenomenon — known as access friction — is a growing concern in healthcare,
-
Antibiotic Resistance Explained: What Overuse Means for Your Health and the Future of Medicine
Antibiotics, Overuse, and Resistance Antibiotics turned once fatal infections into treatable conditions and undergird modern medicine. But overuse and misuse are driving antimicrobial resistance (AMR), threatening those gains. This article explains the science, shows easy to understand real world examples, reviews the evidence from top institutions, and gives clear, practical steps everyone can take —
-
Theme park rides, G-forces, medications and medical risks
Riding roller coasters and other high-thrill attractions exposes the human body to rapid accelerations, sudden directional changes and transient high G-forces. These physical stresses interact with dehydration, sleep loss and many commonly used medications or medical conditions to increase the risk of dizziness, vision loss, loss of consciousness, arrhythmia, neck injury and other adverse events.